Cargando…

Timing of clinically relevant recurrence or true blanking period?

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Ministry of Health and Welfare of Korea The National Research Foundation of Korea (NRF) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) BACKGROUND: Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendsaikhan, P, Park, Y J, Kim, D, Yu, H T, Kim, T H, Uhm, J S, Joung, B, Lee, M H, Pak, H N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207021/
http://dx.doi.org/10.1093/europace/euad122.023
_version_ 1785046356941864960
author Mendsaikhan, P
Park, Y J
Kim, D
Yu, H T
Kim, T H
Uhm, J S
Joung, B
Lee, M H
Pak, H N
author_facet Mendsaikhan, P
Park, Y J
Kim, D
Yu, H T
Kim, T H
Uhm, J S
Joung, B
Lee, M H
Pak, H N
author_sort Mendsaikhan, P
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Ministry of Health and Welfare of Korea The National Research Foundation of Korea (NRF) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) BACKGROUND: Although early recurrence (ER) within 3 months after atrial fibrillation catheter ablation (AFCA) is reportedly considered as a reliable predictor of late recurrence (LR), those ERs are still counted as benign events. There is no large-scale study showing the time limit of true blanking period, nor the potential mechanisms of clinically relevant recurrences within 3 months. PURPOSE: To explore temporal association of ERs with LRs and the presence of extra-pulmonary vein (ExPV) triggers. METHODS: This retrospective, single center study included 2,788 patients undergoing de novo AFCA (median 60 years old, 37.4% persistent AF [PeAF]) with isoproterenol provocation at the procedures. ER and LR were defined as any documented atrial arrhythmia >30s occurring (≤3 months), (>3months) after AFCA respectively. We evaluated the risk factors for ER and LR and compared the risk for LR and existence of ExPV triggers according to different timing of ER. RESULTS: ER was detected in 783 (28.1%) patients. During a median follow-up of 40 months, LR occurred in 945 (33.9%) patients. PeAF (OR 1.79, 95% CI 1.36-2.34), a larger left atrial (LA) diameter (OR 1.03 per 1 mm increase, 95% CI 1.00-1.05), and the existence of ExPV-triggers (OR 3.02, 95% CI 2.08-4.38) were independently associated with ER. ER (HR 2.55, 95% CI 2.15-3.03); the existence of ExPV-triggers (HR 1.63, 95% CI 1.28-2.08), PeAF (HR 1.39, 95% CI 1.16-1.66), and a larger LA diameter (HR 1.02 per 1 mm increase, 95% CI 1.01-1.04) were independent predictors for LR. When stratified according to the days of ER occurrence, ER occurring earlier showed trends toward higher rates of LR (P for trend=0.047) (Figure 1A). Patients with ER occurring within 1 month after AFCA had a higher incidence of LR than those with ER occurring between 2 and 3 months after AFCA (57.5% vs. 49.6%; log-rank P=0.020) (Figure 2B). ER occurring within 1 month after AFCA, compared with no ER, was independently associated with the existence of ExPV triggers (OR 3.99, 95% CI 2.65-6.02) whereas ERs occurring at different timing were not (Figure 1B). CONCLUSIONS: ER, regardless of the timing, and the existence of Ex-PV triggers were independently associated with long-term AF recurrence. Especially, ER occurring earlier within 1 month after AFCA, which was associated with Ex-PV triggers, had the worst rhythm outcome. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102070212023-05-25 Timing of clinically relevant recurrence or true blanking period? Mendsaikhan, P Park, Y J Kim, D Yu, H T Kim, T H Uhm, J S Joung, B Lee, M H Pak, H N Europace 10.2 - Epidemiology, Prognosis, Outcome FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Ministry of Health and Welfare of Korea The National Research Foundation of Korea (NRF) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) BACKGROUND: Although early recurrence (ER) within 3 months after atrial fibrillation catheter ablation (AFCA) is reportedly considered as a reliable predictor of late recurrence (LR), those ERs are still counted as benign events. There is no large-scale study showing the time limit of true blanking period, nor the potential mechanisms of clinically relevant recurrences within 3 months. PURPOSE: To explore temporal association of ERs with LRs and the presence of extra-pulmonary vein (ExPV) triggers. METHODS: This retrospective, single center study included 2,788 patients undergoing de novo AFCA (median 60 years old, 37.4% persistent AF [PeAF]) with isoproterenol provocation at the procedures. ER and LR were defined as any documented atrial arrhythmia >30s occurring (≤3 months), (>3months) after AFCA respectively. We evaluated the risk factors for ER and LR and compared the risk for LR and existence of ExPV triggers according to different timing of ER. RESULTS: ER was detected in 783 (28.1%) patients. During a median follow-up of 40 months, LR occurred in 945 (33.9%) patients. PeAF (OR 1.79, 95% CI 1.36-2.34), a larger left atrial (LA) diameter (OR 1.03 per 1 mm increase, 95% CI 1.00-1.05), and the existence of ExPV-triggers (OR 3.02, 95% CI 2.08-4.38) were independently associated with ER. ER (HR 2.55, 95% CI 2.15-3.03); the existence of ExPV-triggers (HR 1.63, 95% CI 1.28-2.08), PeAF (HR 1.39, 95% CI 1.16-1.66), and a larger LA diameter (HR 1.02 per 1 mm increase, 95% CI 1.01-1.04) were independent predictors for LR. When stratified according to the days of ER occurrence, ER occurring earlier showed trends toward higher rates of LR (P for trend=0.047) (Figure 1A). Patients with ER occurring within 1 month after AFCA had a higher incidence of LR than those with ER occurring between 2 and 3 months after AFCA (57.5% vs. 49.6%; log-rank P=0.020) (Figure 2B). ER occurring within 1 month after AFCA, compared with no ER, was independently associated with the existence of ExPV triggers (OR 3.99, 95% CI 2.65-6.02) whereas ERs occurring at different timing were not (Figure 1B). CONCLUSIONS: ER, regardless of the timing, and the existence of Ex-PV triggers were independently associated with long-term AF recurrence. Especially, ER occurring earlier within 1 month after AFCA, which was associated with Ex-PV triggers, had the worst rhythm outcome. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207021/ http://dx.doi.org/10.1093/europace/euad122.023 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.2 - Epidemiology, Prognosis, Outcome
Mendsaikhan, P
Park, Y J
Kim, D
Yu, H T
Kim, T H
Uhm, J S
Joung, B
Lee, M H
Pak, H N
Timing of clinically relevant recurrence or true blanking period?
title Timing of clinically relevant recurrence or true blanking period?
title_full Timing of clinically relevant recurrence or true blanking period?
title_fullStr Timing of clinically relevant recurrence or true blanking period?
title_full_unstemmed Timing of clinically relevant recurrence or true blanking period?
title_short Timing of clinically relevant recurrence or true blanking period?
title_sort timing of clinically relevant recurrence or true blanking period?
topic 10.2 - Epidemiology, Prognosis, Outcome
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207021/
http://dx.doi.org/10.1093/europace/euad122.023
work_keys_str_mv AT mendsaikhanp timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT parkyj timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT kimd timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT yuht timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT kimth timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT uhmjs timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT joungb timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT leemh timingofclinicallyrelevantrecurrenceortrueblankingperiod
AT pakhn timingofclinicallyrelevantrecurrenceortrueblankingperiod